Consolidated Balance Sheet

Kidswell Bio Corporation - Filing #7297119

Concept As at
2024-09-30
Consolidated balance sheet
Balance sheet
Assets
Current assets
Cash and deposits
1,695,373,000 JPY
Accounts receivable - trade
507,843,000 JPY
Work in process
752,698,000 JPY
Advance payments to suppliers
1,294,971,000 JPY
Other
101,886,000 JPY
Current assets
4,352,772,000 JPY
Non-current assets
293,019,000 JPY
Investments and other assets
290,618,000 JPY
Investment securities
267,593,000 JPY
Other
23,025,000 JPY
Non-current assets
Property, plant and equipment
Property, plant and equipment
1,254,000 JPY
Intangible assets
Intangible assets
1,147,000 JPY
Investments and other assets
Assets
4,645,792,000 JPY
Liabilities
Current liabilities
Accounts payable - other
209,511,000 JPY
Income taxes payable
36,690,000 JPY
Current portion of long-term borrowings
622,040,000 JPY
Other
10,430,000 JPY
Current liabilities
2,193,200,000 JPY
Non-current liabilities
Long-term borrowings
1,009,440,000 JPY
Deferred tax liabilities
44,178,000 JPY
Retirement benefit liability
41,778,000 JPY
Non-current liabilities
1,595,396,000 JPY
Liabilities
3,788,597,000 JPY
Liabilities and net assets
Shareholders' equity
673,725,000 JPY
Share capital
2,159,537,000 JPY
Capital surplus
11,465,138,000 JPY
Retained earnings
-12,950,877,000 JPY
Treasury shares
-73,000 JPY
Valuation and translation adjustments
100,196,000 JPY
Valuation difference on available-for-sale securities
100,196,000 JPY
Share acquisition rights
83,274,000 JPY
Net assets
857,195,000 JPY
Liabilities and net assets
4,645,792,000 JPY
Net assets
Shareholders' equity
Valuation and translation adjustments

Talk to a Data Expert

Have a question? We'll get back to you promptly.